Skip to content

Does targeted dietary advice via telecommunications (video, phone and text) reduce blood phosphate levels in patients with kidney failure on dialysis?

TELEnutrition and KIdNey hEalth – a randomised controlled trial comparing the effect of digital health to standard care on serum phoSphate control in patients on dIalysiS

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000746831
Acronym
The TELEKINESIS study
Enrollment
190
Registered
2021-06-11
Start date
2023-06-27
Completion date
2024-10-30
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Compared to participants who are randomised to the normal care group participants randomised to the intensive telenutrition phosphate control strategy will have lower serum phosphate and reduced intake of high phosphate dietary sources.

Interventions

We aim to recruit participants in Australia who are receiving maintenance dialysis. They will be randomly assigned to either a usual dietetic care group or dietary intervention group. The usual care group will continue to receive standard face to face/telemedicine care provided by the relevant hospital or dialysis unit dietitian. The intervention group will receive standard care plus intensive phosphate lowering education from the research dietitian via identification of high bioavailable dietar

We aim to recruit participants in Australia who are receiving maintenance dialysis. They will be randomly assigned to either a usual dietetic care group or dietary intervention group. The usual care group will continue to receive standard face to face/telemedicine care provided by the relevant hospital or dialysis unit dietitian. The intervention group will receive standard care plus intensive phosphate lowering education from the research dietitian via identification of high bioavailable dietary sources (from nutritional analysis with software program Foodworks), phosphate binder education and food preparation instruction. All instructions will be designed specifically for this trial. This will be done via telenutrition (video and/or phone determined by participant) at baseline (1 x 45 minute), another within one week of the baseline visit (1 x 45 minute) and then will be supported with weekly targeted messages and infographics via a specifically designed App over the next three month period. Messages will be unidirectional, (i.e., one-way with no response required from participants). Content of the messages will include advice, information, reminders, and motivation to support improved serum phosphate levels and quality of life. Messages will be personalised based on baseline dietary intake (from FFQ) and monthly serum phosphate blood tests (normal practice) to three months. Appropriate software will monitor delivery of messages to confirm delivery to participants. The duration of the study (usual care and intervention) is three months, with measurements of serum phosphate, dietary intake (FFQ) and pill burden undertaken at baseline and at the end of the study period. The interviews will be conducted by renal dietitians.

Sponsors

University of Western Australia
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

On dialysis (peritoneal dialysis or haemodialysis (home or facility-based)) for at least 3 months who are able to provide informed consent. Age >= 18 years Patients who are able to read and understand English. Patients who have access to a mobile phone with text message tachnology.

Exclusion criteria

Hospitalisation within the last 1 month Serious intercurrent illness within the last 1 month Unable to complete the FFQ e.g. patients with dementia, cognitive deficit and/or language barrier Patients who are not expected to be dialysis for the forthcoming 3 months

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 19, 2026